Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 191,659 | 189,517 | 87,645 | 145,973 | 133,846 |
| Marketable Securities | 255,564 | 113,406 | 95,978 | 35,592 | 108,928 |
| Receivables | 82,358 | 77,269 | 78,761 | 67,505 | 66,324 |
| Inventories | 8,939 | 9,940 | 10,176 | 6,511 | 4,754 |
| Other current assets | 5,827 | 5,550 | 6,286 | 4,813 | 2,979 |
| TOTAL | $567,593 | $422,082 | $295,931 | $273,212 | $324,270 |
| Non-Current Assets | |||||
| PPE Net | 16,995 | 15,896 | 17,259 | 16,756 | 16,106 |
| Investments And Advances | 36,601 | 28,859 | 22,125 | 0 | 0 |
| Intangibles | 40,020 | 37,423 | 38,083 | 38,057 | 16,074 |
| Other Non-Current Assets | 29,358 | 28,625 | 29,895 | 11,758 | 7,937 |
| TOTAL | $122,974 | $110,803 | $107,362 | $66,571 | $40,117 |
| Total Assets | $690,567 | $532,885 | $403,293 | $339,783 | $364,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 74,407 | 53,127 | 50,065 | 63,590 | 53,839 |
| TOTAL | $295,502 | $253,824 | $207,777 | $186,573 | $159,382 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 216,970 | 195,725 | 152,709 | 122,983 | 105,543 |
| Other Non-Current Liabilities | 13,798 | 197,751 | 79,478 | 190,131 | 107,762 |
| TOTAL | $59,045 | $244,849 | $121,651 | $226,557 | $141,201 |
| Total Liabilities | $354,547 | $498,673 | $329,428 | $413,130 | $300,583 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 188,541 | 75,000 |
| Retained earnings | -164,864 | 118,143 | 199,243 | 78,438 | 28,342 |
| Other shareholders' equity | 2,001 | 965 | 246 | 1,287 | 1,236 |
| TOTAL | $336,020 | $34,212 | $73,865 | $-73,347 | $63,804 |
| Total Liabilities And Equity | $690,567 | $532,885 | $403,293 | $339,783 | $364,387 |